triamterene has been researched along with Diabetic Glomerulosclerosis in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Macleod, MD | 1 |
| Bell, GM | 1 |
| Irvine, WJ | 1 |
| Mioli, V | 1 |
| Zucchelli, P | 1 |
2 other studies available for triamterene and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Nephrogenic diabetes insipidus associated with Dyazide (triamterene-hydrochlorothiazide).
Topics: Aged; Angina Pectoris; Diabetes Insipidus; Diabetic Nephropathies; Diuretics; Drug Combinations; Hum | 1981 |
[The clinical use of an association of hydrochlorothiazide and triamterene in nephrotic syndromes].
Topics: Adolescent; Adult; Aged; Amyloidosis; Child; Diabetic Nephropathies; Diuresis; Electrolytes; Female; | 1966 |